MARKET WIRECNBC • 2h ago
Here are 3 big things we're watching in the stock market in the week aheadThe market could use a few victories in the days ahead, which will be filled with more earnings, an election, and jobs data.
Why MD Stock advanced +0.93% Today — RQD Quant Desk Flash
$29.18 +0.93% NYSE • Live Quote vs Prior Daily Close (Synced Snapshot)
EXT / AFTER-HRS: $29.30
Pediatrix Medical Group Inc. (MD) earns a Roarable Rating of B (Buy) with 74/100 RQD Confidence. High-quality cash engine (steady margins, 34% return on capital) with steady institutional support. The company’s underlying cash engine and institutional positioning keep the composite score in the Green Buy zone.
ROARABLE B • BUY
Cap $2.37B
INTERACTIVE SCENARIO DECK:
EXT / AFTER-HRS: $29.30 (+0.41%)🧬 Cannibal Buyback (-2.64% YoY Shares)⚙️ Cash Engine: 16/20 (B+) • 6.8% FCF Margin
Verify 90D Bucket Audit →📊 Historical Track Record: Scores of 74/100 (B) historically ranked in the Top 12% of excess returns over the next 90 days (+7.3% avg 90D alpha vs SPY • 69.4% hit rate).
Audit Bucket Track Record →RQD QUANT TACHOMETERBUY • B
2-of-3 JEV AI Jury Bullish
Cash
SEC
Whale
Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer
5-PILLAR SNOWFLAKE RADARRw B · Rk B
Each axis scored 0–20
12M PRICE TARGET CONE+7.2% Base Target
WHALE OPTIONS SNAPSHOT: — (No Active Options Snapshot on file for MD)Realized 20D OHLCV Swing Band: ±6.7%
Deterministic 5-Pillar Attribution (74/100 Composite)
🔍 WHY MD SCORES 74/100 (B) — TOP 3 DRIVERS2 Bullish Pillars + #1 Risk Drag
▲ #1 Bullish Driver: Insider Conviction & Share Dilution+17/20 pts (23% of score)
SEC Form 4 / 13F Thermometer: 85% Net Buy • Cannibal Buyback (-2.64% YoY Shares)
▲ #2 Bullish Driver: Cash Engine Quality+16/20 pts (22% of score)
SEC XBRL FY 2025 (10-K): 6.8% FCF Margin ($271.1M FCF) & 52% Gross Margin
▼ #1 Drag / Risk Factor: Whale & Options Positioning12/20 pts (-8 pt drag)
Put hedging (50% put share) caps near-term gamma upside (-8 pts vs max)
📈 PAST 4 QUARTERS RQD vs SUBSEQUENT RETURNQ1 → Q2 → Q3 → Current
Q1 (-3Q)Grade B-$26.64+2.8% Next Q
66
Q2 (-2Q)Grade B-$27.38+7% Next Q
69
Q3 (-1Q)Grade B$29.29-0.4% Next Q
71
CurrentGrade B$29.18+7.3% Hist 90D α
74
Trajectory: B- (66) → B (74)Full Audit →
⚔️ ADVERSARIAL OPPOSING CASE & FORENSIC KILL-SWITCH (WHY THE BULL/BEAR THESIS COULD FAIL)GIDEON ASHMERE // FORENSIC SHORT & KILL-SWITCH DOSSIER
⚔️ Adversarial Opposing Case: Why the MD Bull Thesis Could Fail
Even with a 74/100 (B) score, MD faces multiple-compression risk if 14.3x trailing P/E re-rate toward historical sector medians or if hyperscaler/enterprise customer concentration slows in upcoming 10-Q filings.
⚠️ Forensic Kill-Switch #1
Broader market pullbacks can still drag down strong stocks in the short run.
⚠️ Forensic Kill-Switch #2
Dilution & Margin Drag: Cannibal Buyback (-2.64% YoY Shares) — any gross margin slip below 49.5% triggers an automatic RQD downgrade.
⚠️ Forensic Kill-Switch #3
Technical & Forensic Kill-Switch: A daily close below the 50D SMA ($26.93) or 200D SMA ($23.87) invalidates the momentum regime and cuts Target Base ($31.28) toward Bear Floor ($23.93).
🎲 LIVE PREDICTION MARKET ODDS TIED TO $MD• $2.4M Crowd Pool • Kalshi / Polymarket Composite
Contract: “MD Beats Next Quarter EPS Consensus (Dec 30, 2026) & Holds Above 200D SMA”
AUTOMATED RQD QUANT DESK MOVER BRIEFINGFull Market News Desk →
Why MD Stock advanced +0.93% Today — RQD Quant Desk Flash
Pediatrix Medical Group Inc. (MD) advanced +0.93% to $29.18, trading at 90% of its 52-week range ($17.23 – $30.55). High-quality cash engine (steady margins, 34% return on capital) with steady institutional support.
- ▸Technical Tape: Trading at 90% of its 52-week range ($17.23 – $30.55) with RSI-14 at 71.7 (OVERBOUGHT (>70)).
- ▸Volatility Profile: Historical 20-day realized swing band of ±6.7% around $29.18 (no active unusual options sweep snapshot on file).
- ▸Fundamental Anchor: Roarable B (Buy) backed by 52% gross margin and $271.1M annual free cash flow.
Live MD Headlines & Catalysts
MARKET WIRECNBC • 2h ago
Democratic Rep. Stevens endorses Rogers over El-Sayed in Michigan Senate electionHaley Stevens had lost the Democratic nomination for Senate in Michigan to Abdul El-Sayed earlier this year.
RISK WATCHReuters • 4h ago
Israeli strikes kill eight people in Gaza - medics say - ReutersIsraeli strikes kill eight people in Gaza - medics say Reuters
MARKET WIREReuters • 5h ago
Russia's FSB says minor detained over park attack threat after US tip-off - ReutersRussia's FSB says minor detained over park attack threat after US tip-off Reuters
MARKET WIREReuters • 6h ago
Iran, Qatari mediators hold third day of talks to end US-Iran war - ReutersIran, Qatari mediators hold third day of talks to end US-Iran war Reuters
CATALYSTReuters • 6h ago
Qatar surges, bucking Gulf market slide on Iran war concerns - ReutersQatar surges, bucking Gulf market slide on Iran war concerns Reuters
MARKET WIREReuters • 7h ago
OPEC+ keeps December oil output targets steady ahead of tougher call for 2027 - ReutersOPEC+ keeps December oil output targets steady ahead of tougher call for 2027 Reuters
MARKET WIREReuters • 7h ago
German ministers pledge tough action after rioters damage stores in Frankfurt - ReutersGerman ministers pledge tough action after rioters damage stores in Frankfurt Reuters
ON-DEMAND RQD QUANT WORKSHOP • SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher & Roarable Quantitative Research Desk
Scheduled RQD Strong Buys & Whale Accumulation Briefing (MD Tape Review)
- ✓Breakdown of the highest-scoring RQD Green-Light breakouts across our 5,200+ rated universe
- ✓Forensic Red-Light accounting & dilution traps to review on your watchlist
- ✓Includes downloadable .ics calendar invite & nightly RQD rating-change email alerts
RQD INSIDER CLUB WAITLIST$49/YR PLANNED
Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?
MD // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: +29.63%▲ ASCENDING CHANNEL
2026-10-30O $29.48H $29.97L $29.07C $29.18VOL 1.11M
RES: $30.35SUP: $25.55SMA50: $26.93SMA200: $23.87
PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK
MD Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure
Share Count & Dilution Monitor (#25)
Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).
Reverse-DCF Expectations Hurdle (#30)
6.2%/yr Implied 5Y Growth
vs. +6.0% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).
Ellis Vennor Setup Ledger (#33)
No active Ellis Vennor swing setup published on MD today. View full Setup Ledger →
🦋 Documented & Second-Order Butterfly Connections
Open Graph →
No direct multi-tier Butterfly edges indexed yet for MD. Explore sector supply chains on /butterfly.
AI Analyst Theses, Washington Policy & Company Video
🎬 No recent verified company-specific video clip queued for MD today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →
DETERMINISTIC MULTI-FACTOR EQUITY AUDIT • SEC EDGAR XBRL × RQD PEER BENCHMARK
📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (MD)
Health Care Rank #53 of 1016
⚔️ BKD vs MD Full Matrix →
1. Head-to-Head Health Care Peer Comparison (MD vs. BKD, SGRY, ARDT, NHC)
Industry: Hospital/Nursing Management (14 Tracked Issuers)Across 1016 tracked Health Care securities in the Roarable RQD universe, Pediatrix Medical Group Inc. (MD) ranks #53 by composite RQD confidence (74/100, grade B) and #228 by equity capitalization ($2.37B). Within this direct 5-issuer industry benchmark cohort, ARDT leads on earnings valuation at 12.8x trailing P/E, while MD leads on capital efficiency and profitability with 33.6% ROIC and — gross margin. MD currently leads its immediate peer cohort in composite quantitative strength at 74/100 (B).
| Ticker / Company | Roarable Grade | RQD Score | Trailing P/E | Gross Margin | ROIC | 1D Change | Market Cap | Head-to-Head |
|---|---|---|---|---|---|---|---|---|
| MD
ACTIVE
Pediatrix Medical Group Inc. | B | 74/100 | 14.3x | — | 33.6% | +0.93% | $2.37B | Benchmark Subject |
| BKD Brookdale Senior Living Inc. | D | 46/100 | — | 26.2% | 0.3% | +2.91% | $2.45B | /bkd-vs-md → |
| SGRY Surgery Partners Inc. | C+ | 66/100 | — | — | 9.9% | -0.13% | $3.04B | /sgry-vs-md → |
| ARDT Ardent Health Inc. | C+ | 67/100 | 12.8x | — | 10.5% | +3.10% | $1.73B | /ardt-vs-md → |
| NHC National HealthCare Corporation | C+ | 69/100 | 27.7x | — | 10.1% | +0.18% | $3.32B | /nhc-vs-md → |
2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2023–FY2025)
SEC EDGAR 10-K • FILED 2025-12-31 • CIK 0000893949In its most recent audited fiscal period (FY2025, filed 2025-12-31), Pediatrix Medical Group Inc. (MD) reported GAAP revenue of $0 (N/A vs. FY2024 revenue of $0 ) , GAAP net income of $165.4M, operating cash flow of $271.1M, and free cash flow of $271.1M (+31.2% YoY). On the balance sheet, MD closed FY2025 with $2.25B in total assets against $0 in total debt (Altman Z-Score: N/A, Piotroski F-Score: 6/9).
| Fiscal Period | Filing Date | Revenue | Net Income | Operating Cash Flow | Free Cash Flow | Total Assets | Total Debt |
|---|---|---|---|---|---|---|---|
| FY2025 (FY) | 2025-12-31 | $0 | $165.4M | $271.1M | $271.1M | $2.25B | — |
| FY2024 (FY) | 2024-12-31 | $0 | -$99.1M | $206.6M | $206.6M | $2.15B | — |
| FY2023 (FY) | 2023-12-31 | $0 | -$60.4M | $137.3M | $137.3M | — | — |
3. MD Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)
✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLEDIs MD stock a Buy, Hold, or Sell right now according to Roarable's RQD model?
As of 2026-11-01, Pediatrix Medical Group Inc. (NYSE: MD) is rated B (Buy / BUY) by Roarable's 5-pillar RQD engine with a composite confidence score of 74/100 at a spot price of $29.18 (+0.93% 1D, market cap $2.37B). Pillar breakdown: Fundamental Cash Engine 16/20, Institutional 13F & Options Flow 12/20, Executive Insider Alignment 13/20, FRED Macro Regime Fit 16/20, and SEC Balance-Sheet Forensics 17/20. Across 1016 tracked Health Care issuers, MD ranks #53 in composite RQD confidence.
How does MD compare to BKD and SGRY in the Health Care sector?
Within the Health Care sector (Hospital/Nursing Management), MD carries a Roarable B (74/100 RQD), trailing P/E of 14.3x, gross margin of —, and ROIC of 33.6%. By comparison, BKD (Brookdale Senior Living Inc.) holds a D grade (46/100 RQD, P/E N/A, ROIC 0.3%, cap $2.45B) and SGRY (Surgery Partners Inc.) posts a C+ grade (66/100 RQD, P/E N/A, ROIC 9.9%, cap $3.04B). Among the 5-stock peer group, ARDT leads on earnings multiple (12.8x) while MD leads on capital efficiency (33.6% ROIC).
What are the biggest fundamental strengths and SEC risk factors for MD?
Per MD's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0000893949), Pediatrix Medical Group Inc. generated $0 in revenue, $165.4M in net income, and $271.1M in free cash flow against $2.25B in total assets and $0 in total debt. Key quantitative strengths: Strong cash generator (steady margins)—profits are backed by real money, not accounting tricks.. Primary risk factors monitored: Broader market pullbacks can still drag down strong stocks in the short run.. Institutional options positioning shows a 50% call / 50% put premium split.
Where is MD trading relative to its 50-day, 200-day, and 52-week technical levels?
MD last traded at $29.18 (+0.93% on volume of 832,584 shares), positioning the stock +8.35% above its 50-day simple moving average ($26.93) and +22.25% above its 200-day simple moving average ($23.87). Across its 52-week range of $17.23 to $30.55, MD sits at the 89.7% percentile with a 14-day RSI of 71.7 (OVERBOUGHT (>70)) and an implied next-earnings move of ±6.7% ($27.22 to $31.14).
MD Investor FAQ & Complete 8-Part Research Index
100% OPEN ACCESS • SEC EDGAR × CBOE × FREDWhy is MD stock moving today?
Why MD Stock advanced +0.93% Today — RQD Quant Desk Flash. High-quality cash engine (steady margins, 34% return on capital) with steady institutional support.